Research

The Leadership Sinai Centre for Diabetes (LSCD) has a leadership role in advancing diabetes research and care locally, provincially, nationally and internationally, ranking among the top in the world in diabetes research. Because clinicians work closely with researchers, patients have the opportunity to participate in clinical trials.

The LSCD is dedicated to clinical research in the area of diabetes care, the prevention of diabetes in high risk individuals, the study of gestational diabetes, the evaluation of diabetes in Indigenous populations, the study of therapies to prevent complications, the role of genetics in determining complication susceptibility and the assessment of new therapies for both type 1 and type 2 diabetes. As an example the LSCD continues to play a leadership role in the landmark Diabetes Control and Complications Trial (DCCT) and its’ follow up study. This study demonstrated conclusively the value of intensive therapy in type 1 diabetes and set the standard for the clinical management of this condition. As a result the LSCD was amongst the first centres to translate the findings of the DCCT into the everyday care of people with diabetes.

The research programs of the LSCD are funded by grants from prestigious organization such as the National Institute of Health (NIH) in the United States, the Canadian Institutes for Health Research (CIHR), Diabetes Canada, as well as industry.

Get Involved

Leadership Sinai Centre for Diabetes (LSCD) conducts research through clinical trials and observational studies. Our centre also engages in quality improvement projects. Patients of LSCD may be asked by clinical team members (endocrinologist, nurse, or dietitian) if they are interested in participating a research study.  

All clinical trials are conducted under the protocols of Canadian Standards for research and the conduct of randomized controlled trials. All protocols are approved by the Research Ethics Board.